The Velcade Brand and generic had U.S. sales of approximately $1.2 billion MAT for the most recent twelve months ending in May 2022
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Govt committed to supporting pharma companies with industry-friendly policies
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
Company hires life science veteran Jessica Cao to join management team
Subscribe To Our Newsletter & Stay Updated
